SIGAL ELLIOT 4
4 · Spark Therapeutics, Inc. · Filed May 31, 2018
Insider Transaction Report
Form 4
SIGAL ELLIOT
Director
Transactions
- Exercise/Conversion
Common Stock
2018-05-31+1,500→ 12,714 total - Award
Restricted Stock Units
2018-05-30+1,500→ 1,500 total→ Common Stock (1,500 underlying) - Award
Stock Option (right to buy)
2018-05-30+4,000→ 4,000 totalExercise: $81.53Exp: 2028-05-29→ Common Stock (4,000 underlying) - Exercise/Conversion
Restricted Stock Units
2018-05-31−1,500→ 0 total→ Common Stock (1,500 underlying)
Footnotes (5)
- [F1]Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock.
- [F3]100% of the restricted stock units vest on the one-year anniversary of the grant date. Vested shares will be delivered to the reporting person on the vesting date.
- [F4]100% of the shares vest on the one-year anniversary of the grant date.
- [F5]On May 31, 2017, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date. Vested shares are delivered to the reporting person on the vesting date.